Gastroenterology Research Review, Issue 60

In this issue:

Risankizumab for moderate-tosevere CD
Multimodal treatment for CD with perianal fistulae
5-ASAs don’t benefit UC patients escalated to biologic therapy
Biologic exposure via breastmilk and infection/development
Vedolizumab after anti-TNF failure in paediatric IBD
H. pylori reduces Barrett’s oesophagus risk
Optimised thiopurine therapy before anti-TNF withdrawal in CD
Dietary fibre decreases faecal incontinence risk in older women

Please login below to download this issue (PDF)

Subscribe